BACKGROUND: There are limited data on large-scale, multilevel implementation research studies to improve hypertension diagnosis, treatment, and control rates at the primary healthcare (PHC) level in Africa. We describe the characteristics, treatment, and control rates of patients with hypertension in public PHC centers in the Hypertension Treatment in Nigeria Program. METHODS: Data were collected from adults at least 18 years at 60 public PHC centers between January 2020 and November 2020. Hypertension treatment rates were calculated at registration and upon completion of the initial visit. Hypertension control rates were calculated based on SBP and DBPs less than 140/90 mmHg. Regression models were created to evaluate factors associated with hypertension treatment and control status. RESULTS: Four thousand, nine hundred and twenty-seven individuals [66.7% women, mean (SD) age = 48.2 (12.9) years] were included. Mean (SD) SBP was higher in men compared with women [152.9 (20.0) mmHg versus 150.8 (21) mmHg, P = 0.001]. Most (58.3%) patients were on treatment at the time of registration, and by the end of the baseline visit, 89.2% of patients were on treatment. The baseline hypertension control rate was 13.1%, and control was more common among patients who were older [adjusted OR (95% CI) 1.01 [1.01 -1.02)], women [adjusted OR (95% CI) 1.30 (1.05- 1.62)], who used fixed dose combination therapy [adjusted OR (95% CI) 1.83 (1.49 -2.26)], and had higher education levels. CONCLUSION: This baseline report of the largest facility-based hypertension study in Africa demonstrates high hypertension treatment rates but low control rates.
BACKGROUND: There are limited data on large-scale, multilevel implementation research studies to improve hypertension diagnosis, treatment, and control rates at the primary healthcare (PHC) level in Africa. We describe the characteristics, treatment, and control rates of patients with hypertension in public PHC centers in the Hypertension Treatment in Nigeria Program. METHODS: Data were collected from adults at least 18 years at 60 public PHC centers between January 2020 and November 2020. Hypertension treatment rates were calculated at registration and upon completion of the initial visit. Hypertension control rates were calculated based on SBP and DBPs less than 140/90 mmHg. Regression models were created to evaluate factors associated with hypertension treatment and control status. RESULTS: Four thousand, nine hundred and twenty-seven individuals [66.7% women, mean (SD) age = 48.2 (12.9) years] were included. Mean (SD) SBP was higher in men compared with women [152.9 (20.0) mmHg versus 150.8 (21) mmHg, P = 0.001]. Most (58.3%) patients were on treatment at the time of registration, and by the end of the baseline visit, 89.2% of patients were on treatment. The baseline hypertension control rate was 13.1%, and control was more common among patients who were older [adjusted OR (95% CI) 1.01 [1.01 -1.02)], women [adjusted OR (95% CI) 1.30 (1.05- 1.62)], who used fixed dose combination therapy [adjusted OR (95% CI) 1.83 (1.49 -2.26)], and had higher education levels. CONCLUSION: This baseline report of the largest facility-based hypertension study in Africa demonstrates high hypertension treatment rates but low control rates.
Authors: Katherine T Mills; Katherine M Obst; Wei Shen; Sandra Molina; Hui-Jie Zhang; Hua He; Lisa A Cooper; Jiang He Journal: Ann Intern Med Date: 2017-12-26 Impact factor: 25.391
Authors: Pascal Geldsetzer; Jennifer Manne-Goehler; Maja-Emilia Marcus; Cara Ebert; Zhaxybay Zhumadilov; Chea S Wesseh; Lindiwe Tsabedze; Adil Supiyev; Lela Sturua; Silver K Bahendeka; Abla M Sibai; Sarah Quesnel-Crooks; Bolormaa Norov; Kibachio J Mwangi; Omar Mwalim; Roy Wong-McClure; Mary T Mayige; Joao S Martins; Nuno Lunet; Demetre Labadarios; Khem B Karki; Gibson B Kagaruki; Jutta M A Jorgensen; Nahla C Hwalla; Dismand Houinato; Corine Houehanou; Mohamed Msaidié; David Guwatudde; Mongal S Gurung; Gladwell Gathecha; Maria Dorobantu; Albertino Damasceno; Pascal Bovet; Brice W Bicaba; Krishna K Aryal; Glennis Andall-Brereton; Kokou Agoudavi; Andrew Stokes; Justine I Davies; Till Bärnighausen; Rifat Atun; Sebastian Vollmer; Lindsay M Jaacks Journal: Lancet Date: 2019-07-18 Impact factor: 79.321
Authors: Abdul Salam; Mark D Huffman; Raju Kanukula; Esam Hari Prasad; Abhishek Sharma; David J Heller; Rajesh Vedanthan; Anubha Agarwal; Anthony Rodgers; Marc G Jaffe; Thomas R Frieden; Sandeep P Kishore Journal: J Clin Hypertens (Greenwich) Date: 2020-08-20 Impact factor: 3.738
Authors: Dike B Ojji; Elena Libhaber; John J Atherton; Bolaji Abdullahi; Ada Nwankwo; Karen Sliwa Journal: Medicine (Baltimore) Date: 2015-09 Impact factor: 1.817
Authors: Mark D Huffman; Dike B Ojji; Abigail S Baldridge; Kasarachi Aluka-Omitiran; Ikechukwu A Orji; Gabriel L Shedul; Tunde M Ojo; Helen Eze; Grace Shedul; Eugenia N Ugwuneji; Nonye B Egenti; Rosemary C B Okoli; Boni M Ale; Ada Nwankwo; Samuel Osagie; Jiancheng Ye; Aashima Chopra; Olutobi A Sanuade; Priya Tripathi; Namratha R Kandula; Lisa R Hirschhorn Journal: Implement Sci Commun Date: 2022-08-02
Authors: Jiancheng Ye; Ikechukwu A Orji; Abigail S Baldridge; Tunde M Ojo; Grace Shedul; Eugenia N Ugwuneji; Nonye B Egenti; Kasarachi Aluka-Omitiran; Rosemary C B Okoli; Helen Eze; Ada Nwankwo; Lisa R Hirschhorn; Aashima Chopra; Boni M Ale; Gabriel L Shedul; Priya Tripathi; Namratha R Kandula; Mark D Huffman; Dike B Ojji Journal: JAMA Netw Open Date: 2022-09-01